Potential treatment to improve heart health in hemodialysis patients
1/18/2014
Researchers at Wayne State University have discovered a potential way to improve the lipid profiles in patients undergoing hemodialysis that may prevent cardiovascular disease common in these patients. Patients undergoing hemodialysis for kidney failure are at a greater risk for atherosclerosis, a common disease in which plaque builds up inside the arteries.
NORD commends expansion of SSA's "Compassionate Allowances" list
1/17/2014
Peter L. Saltonstall, president and CEO of the National Organization for Rare Disorders (NORD), has praised the Social Security Administration's announcement that 25 additional medical diagnoses would be added to SSA's Compassionate Allowances initiative.
Research led by the Translational Genomics Group at Vall d'Hebron Institute of Oncology (VHIO) in Barcelona has not only shown that HER2+ breast cancer can be classified into four different subtypes, but also unmasked a subtype showing both a greater response to and increased benefit from chemotherapy and anti-HER2 therapy.
New research from the MRC Clinical Sciences Centre suggests that nutrients in the diet may play a role in changing the architecture of blood vessels in the gut and other organs. The study, in fruit flies, found that small changes in their diet alter the nerve signalling that guides branching of new oxygen-delivering tubules - a process reminiscent of adaptive angiogenesis.
Breakthrough announced in treatment of patient with rare type of leukaemia
1/17/2014
A team of scientists from the University of Leicester has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a rare type of blood cancer, using a drug administered to combat skin cancer.
'Precision medicine' successfully targets advanced form of leukaemia with skin cancer drug
1/17/2014
A team of scientists from the University of Leicester has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a rare type of blood cancer, using a drug administered to combat skin cancer.
Analysis of hundreds of tumor marker proteins at once made possible by 'barcode' profiling
1/17/2014
A new technology developed at the Massachusetts General Hospital (MGH) Center for Systems Biology (CSB) allows simultaneous analysis of hundreds of cancer-related protein markers from miniscule patient samples gathered through minimally invasive methods.
Masquerading as neurons enables breast cancer cells to spread to the brain
1/17/2014
Often, several years can pass between the time a breast cancer patient successfully goes into remission and a related brain tumor develops. During that time, the breast cancer cells somehow hide, escaping detection as they grow and develop. Now City of Hope researchers have found out how.Breast cancer cells disguise themselves as neurons, becoming "cellular chameleons," the scientists found.
Major potential advance in the search for new treatment for cancers caused by viruses
1/17/2014
Christopher Parsons, MD, Director of the HIV Malignancies Program at LSU Health Sciences Center New Orleans, is the senior author of a paper that is the first to report that specialized fat (lipid) molecules, called sphingolipids, play a key role in the survival of aggressive lymphomas caused by viruses.
High risk of poor Pap tests for female-to-male transgender patients
1/17/2014
Before the introduction of cervical cancer screenings, the disease used to be the leading cause of cancer death for women in the US. Though it is now the 14th cause of death, new research suggests that compared with female patients, female-to-male transgender patients are much more likely to have inadequate cell samples taken during screening.The research team, led by Dr.